John J. McCabe
2016
In 2016, John J. McCabe earned a total compensation of $607.8K as Chief Financial Officer at Eleven Biotherapeutics.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $227,846 |
| Salary | $305,000 |
| Total | $607,846 |
McCabe received $305K in salary, accounting for 50% of the total pay in 2016.
McCabe also received $75K in bonus and $227.8K in option awards.
Rankings
In 2016, John J. McCabe's compensation ranked 10,488th out of 14,075 executives tracked by ExecPay. In other words, McCabe earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,488 out of 14,075 | 26th |
Division Manufacturing | 4,052 out of 5,489 | 26th |
Major group Chemicals And Allied Products | 1,433 out of 1,895 | 24th |
Industry group Drugs | 1,148 out of 1,538 | 25th |
Industry Pharmaceutical Preparations | 897 out of 1,176 | 24th |
Source: SEC filing on April 7, 2017.
McCabe's colleagues
We found four more compensation records of executives who worked with John J. McCabe at Eleven Biotherapeutics in 2016.